2008
DOI: 10.1161/strokeaha.108.523662
|View full text |Cite
|
Sign up to set email alerts
|

Patterns of Brain Arteriovenous Malformation Treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
12
0

Year Published

2009
2009
2017
2017

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 20 publications
(13 citation statements)
references
References 36 publications
(35 reference statements)
1
12
0
Order By: Relevance
“…Geographical differences could thus be expected in the choice of treatment, which is shown in Table 3. In accordance with other reports, we thus observe that preference and local expertise exert considerable influence on the selection of treatment modality [2].…”
Section: Treatment and Complicationssupporting
confidence: 92%
“…Geographical differences could thus be expected in the choice of treatment, which is shown in Table 3. In accordance with other reports, we thus observe that preference and local expertise exert considerable influence on the selection of treatment modality [2].…”
Section: Treatment and Complicationssupporting
confidence: 92%
“…[16] In two population based studies, 38% and 65% of patients with AVM had hemorrhage, with a peak incidence in the fifth decade of age. Although hemorrhage from an AVM can be disabling or deadly, the course in many non-operated high-grade AVMs (Spetzler Martin grades 4 and 5) can be quite benign, if compared with their intervention risk.…”
Section: Discussionmentioning
confidence: 99%
“…18 Adults receiving interventional treatment inevitably incurred higher direct costs, and the influence of AVM nidus size was likely to be a reflection of the feasibility of treatment (in our dataset, 76% of those with a nidus Ͻ30 mm were treated, compared with 57% of those 30 to 59 mm and 14% of those Ն60 mm). 19 The burden associated with lost productivity was even greater than the healthcare costs (especially for those who died prematurely), reflecting the disabling (and sometimes fatal) nature of IVMs predominantly among adults of working age-these costs are likely to be even greater if considered over adults' lifetimes (especially in view of the risk of recurrent hemorrhage from IVMs). Just as the healthcare costs of CMs were much lower than AVMs, the costs of lost productivity seemed to be lower, too (Table 3, Pϭ0.1), but the lack of statistical significance may be a false-negative result attributable to the small sample size and the nonparametric statistics used.…”
Section: Discussionmentioning
confidence: 99%